Cookie Img
Home » Products » Lung Cancer Medicines » Iressa 250 Mg Tablet

Iressa 250 Mg Tablet

Iressa 250 Mg Tablet
Iressa 250 Mg Tablet
Send Inquiry
Product Code : 04
Price And Quantity
  • Minimum Order Quantity
  • 1 Crore Piece
  • Price
  • 32000 INR
Product Specifications
  • Drug Type
  • Specific Drug
  • Physical Form
  • Tablets
  • Function
  • Anti-Cancer
  • Recommended For
  • Lung Cancer
  • Dosage
  • 250 Mg
  • Suitable For
  • Adults
Product Description

Having immense expertise in this domain, we are betrothed in offering supreme grade Iressa 250 Mg Tablet. Widely used as a cancer chemotherapy medication, this tablet is widely consumed by patients in the treatment of non-small cell lung cancer. Provided tablet is processed using quality-assured cancer chemotherapeutic agents by adept pharmacists. Available in secure packing, this Iressa 250 Mg Tablet can be bought within prescribed delivery time by our valued clients.

Iressa is a cancer medicament, which interferes with the development and outspread of cancer cells in the human body. Put-upon to treat non-small cell lung cancer, it is erstwhile utilized to treat cancer, which has spread to some other parts of the body. The medication should only be taken under the direction of a well-qualified healthcare provider who is experienced in the usage of cancer chemotherapeutic agents.
Before taking Iressa :

Don’t take it if you have a hypersensitivity reaction to gefitinib.

To make sure it is risk-free for you, inform the doctor if you have:
  •     Liver disease
  •     Kidney disease
  •     Vision difficulties
  •     Lung disease other than lung cancer, breathing problems
  •     If you use a blood thinner (Coumadin, warfarin, Jantoven).
Key Points:
  • Long shelf life
  • Non hazardous
  • Excellent effectiveness
  • Accurate composition
Trade Information
  • Payment Terms
  • Cash in Advance (CID), Cash Advance (CA)
  • Supply Ability
  • 1 Piece Crore Per Week
  • Delivery Time
  • 1 Week
  • Main Export Market(s)
  • Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia


Developed and Managed by Infocom Network Ltd.